NIH-funded research Fellowship grant

Finding new antimicrobial peptides from soil bacteria.

Official title: Identification and Biosynthesis of Dehydrated Nonribosomal Peptides from Streptomyces

Funded at Univ of North Carolina Chapel Hill · NIH-11115555 · Data updated 2026-11-12

This study is looking for new natural compounds from soil bacteria that can help fight infections, especially those that are hard to treat because they resist antibiotics, and it's for anyone interested in better ways to tackle these tough germs.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJune 1, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$78,040
NIH project number5F32GM154449-02
Project IDNIH-11115555 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from infections caused by antimicrobial-resistant bacteria.

Less likely to help

Patients with infections that are not caused by antimicrobial-resistant microorganisms may not benefit from this research.

What this research studies

This research focuses on identifying and developing new nonribosomal peptides, which are natural compounds that can act as antimicrobials. The team will explore specific peptides that are derived from soil bacteria, particularly Streptomyces, and investigate their biosynthetic pathways. By utilizing advanced genome mining techniques, they aim to uncover the structures and functions of these peptides, which could lead to new treatments for infections caused by antimicrobial-resistant microorganisms.

Why it matters

Potential benefit: If successful, this research could lead to the development of novel antimicrobial therapies that effectively combat resistant infections.

How similar studies have gone: Previous research has shown promise in identifying bioactive nonribosomal peptides, indicating that this approach could lead to significant advancements in antimicrobial therapy.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Mull, Ryan Wyatt — Univ of North Carolina Chapel Hill
  • Study coordinator: Mull, Ryan Wyatt

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.